Italian drugmaker Chiesi to buy KalVista for $1.9 billion

Italy's ​Chiesi has ‌agreed to ​buy ​KalVista Pharmaceuticals ⁠for ​about $1.9 billion, the ​company said on ​Wednesday, ​as it ‌looks ⁠to grow its ​rare ​disease ⁠drug portfolio.